Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - large image1
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image1
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image2
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image3
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image4
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image5
TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8 buy - image6

TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8

TDS 2028 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

medicinal Grade

Content:

99%

Port:

china any port

Brand:

TNJONE

Packaging:

5mg/10mg/15mg per vial; 1g,10g or according to customer's detail requirement.

Price valid (until):

2025-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,API,Vitamins,Food Additive

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Product Description


    Tirzepatide is used to improve glycaemic control in adults with type 2 diabetes. It is the first glucose-dependent dual agonist of glucagonotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. According to its SURPASS series of studies, the highest dose of 15mg further reduces HbA1C by up to 1.6% absolute compared to placebo. In addition to its glucose-lowering effects, the SURMOUNT-1 study in obese patients without diabetes showed that the highest dose of 15 mg of Tirzepatide significantly reduced patient body weight by an average of 22.5% (24 kg).
    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 1
    A
    pplications:

    --Helps slow food leaving your stomach
    --Helps prevent your liver from making too much sugar
    --Helps the pancreas produce more insul when your blood sugar levels are high
    --Can help control blood glucose
    --Can reduce hyperglycemia, especially after meals
    --Can reduce fasting insul and fasting glucose
    --Can reduce hemoglobin A1c
    --Can decrease appetite and caloric intake, while inhibiting weight gain
    --Has been shown to lower triglyceride levels and oxidative stress from high LDL
    --Has been shown to help induce weight loss in obese patients with higher dosing
    --Helps decrease leptin and increase leptin sensitivity
    --Can increase the conversion of white fat to brown fat
    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 2


      Product Name: Tirzepatide
      Cas No. 2023788-19-2
      Purity: 99%
       Status: Solid State
       ackage
    Foil Bag or Box
       Specification 2mg/vial, 5mg/vial, 10mg/vial, 15mg/vial
       Shelf Life 2 Years


    CERTIFICATE OF ANALYSIS

     

    Product Name Tirzepatide (LY3298176)
    Sequence Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu- Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
    Quality Standard In-house Batch No. ZB10023106
    CAS No. 2023788-19-2 Batch Quantity 1013.1g
    Molecular Formula C225H348N48O Manufacturing Date 24-Aug-2023
    Molecular Mass 4813.45 Retest Date 24-Aug-2025

     

    Tests Specifications Results
    Characters Appearance White to almost white loose powder White loose powder
    Solubility Soluble in water Complies
    Identifications HPLC The retention time of the major peak in the chromatogram of the test solution corresponds to that in the chromatogram of the Reference Solution, as obtained in the Assay Complies
    MALDI-MS 4813.5±1.0 Da 4812.6 Da
    Amino acid analysis
    Ser: 4.0-6.0 4.6

    Asp: 1.6-2.4 1.6

    Thr: 1.6-2.4 1.8

    Pro: 3.2-4.8 4.1

    Tyr: 1.6-2.4 2.1

    Leu: 1.6-2.4 1.9

    Gly: 3.2-4.8 4.0

    Glu: 3.2-4.8 3.8

    Ala: 3.2-4.8 3.9

    Lys: 1.6-2.4 1.9

    Ile: 2.4-3.6 3.0

    Phe: 1.6-2.4 2.2
    Peptide Purity (HPLC)
    ≥ 80% 93.6%
    Related Substances Impurities (HPLC) Any unspecified impurity  ≤ 0.10% 0.06%
    Toal impurities ≤ 0.50% 0.12%
    Oligomer
    ≤ 3.0% 0.27%
    Water content (KF)
    ≤ 8.0% 4.63%
    Sodium ion
    Report 1.1%
    Residual solvents (GC)
    Acetonitril-e ≤ 410 ppm 246 ppm
    Bacterial Endotoxins
    ≤ 10 EU/mg Complies
    Microbiology Total aerobic microbial count ≤ 100 CFU/g < 10 CFU/g
    Total combined yeasts and moulds count ≤ 100 CFU/g < 10 CFU/g
    Escherichia coli count Absent in 1g Complies
    Assay Calculated as C18H14F4N2O4S on dried substance 98.0% - 102.0% 99.8%

     

    Storage condition: 2°C - 8°C, well-closed containers, protected from light.
    Remarks: This batch of product COMPLIES with the prescribed standards.
    Analysed on: 23.12.2023


      Company Profile  


    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 3

    Shaanxi TNJONE Pharmaceutical Co., Ltd is a high-tech enterprise mainly engaged inthe development and sale of pharmaceutical chemical raw materials and relatedproducts.The company has advanced and perfect supporting system,forming advancedchemical synthesis technology, which can quickly meet the individual needs and serialdevelopment from suitable detection to industrial production.Qur business covers morethan 30 countries, most of customers from Europe, Southeast Asia and other countriesin the world, we can guarantee the quality and price. Our enterprise purpose is basedon the market, strengthen strength, take the road of scientific environmental protectionand sustainable development, rely on the country. The company has a strong financialstrength and a good business environment, can provide customers with quality,efficientand fast service.

    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 4


     Our factory   


    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 5 Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 6

    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 7 Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 8

    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 9

    Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 10 Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 11 Shop TNJONE 99% Tirzepatide CAS 2023788-19-2 Treatment of Obesity with Low Price 200-001-8-Detailed Image 12


      How to order  


    Before ordering Please send what items and what quantity you need
    Send quotation We will send you a quotation in detail with total
    Payment ways chosen Please choose one of the payment way you preferred.
    Our payment ways: City bank,BTC,Bank wire, Wise,Master Card , Tether
    After payment Please offer shipping address after payment for shipment.
    Tracking We will provide the tracking after goods sent.
    Lead time About 1-5 working days after payment
    Shipping time About 8-15 days door to door
    After-sale service Available always


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,API,Vitamins,Food Additive

    Location:

    No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New City, Xi 'an, Shaanxi Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    5

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

    Shaanxi TNJONE Pharmaceutical Technology Co., LTD., located in the beautiful ancient capital Xi 'an, is committed to the peptide industry, pharmaceutical raw materials, food and feed additives, veterinary drugs and other fields, the enterprise adhering to provide customers with quality service, supply high-quality products, "world peace and health" as its responsibility, the company adhering to the "meet all customer requirements for products" as the service concept, Guarantee "provide qualified products" as the service principle, so that you get "God-like" noble shopping enjoyment. Our company has more than 1000 kinds of polypeptides, raw materials inventory, at any time to meet the various needs of customers for products. Is your best partner.
  • Inquiry History
    2028 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.